OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
Zhang-Xian Xiao, Mingxi Li, Xiaoqian Zhang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 12
Zhang-Xian Xiao, Mingxi Li, Xiaoqian Zhang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 12
Showing 12 citing articles:
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 5
Gang Wang, Xiaodi Jiang, Pedram Torabian, et al.
Cancer Letters (2024) Vol. 588, pp. 216744-216744
Open Access | Times Cited: 5
Targeting Thyroid Hormone Receptor Interacting Protein (TRIP13) for Cancer Therapy: A Promising Approach
Surya P. Singh, Krishnendu Goswami, Gopal Pathuri, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Surya P. Singh, Krishnendu Goswami, Gopal Pathuri, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?
Ahmed M. Elshazly, Jingwen Xu, Nebras Y. Melhem, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2989-2989
Open Access | Times Cited: 3
Ahmed M. Elshazly, Jingwen Xu, Nebras Y. Melhem, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2989-2989
Open Access | Times Cited: 3
Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1 /TAZ expression
Shi Li, Banzhan Ruan, Zhi Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 23, pp. 3744-3759
Open Access | Times Cited: 6
Shi Li, Banzhan Ruan, Zhi Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 23, pp. 3744-3759
Open Access | Times Cited: 6
Targeting TRIP13 for overcoming anticancer drug resistance (Review)
Liwen Zhao, Siyu Ye, Shengnan Jing, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 6
Liwen Zhao, Siyu Ye, Shengnan Jing, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 6
TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
TRIP13 − a potential drug target in cancer pharmacotherapy
Samuel J. Bunu, Haiyan Cai, Leyun Wu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107650-107650
Closed Access | Times Cited: 1
Samuel J. Bunu, Haiyan Cai, Leyun Wu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107650-107650
Closed Access | Times Cited: 1
Role of TRIP13 in human cancer development
Chaohu Chen, Li Pan, Guangrui Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Chaohu Chen, Li Pan, Guangrui Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5571-5571
Open Access | Times Cited: 3
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5571-5571
Open Access | Times Cited: 3
An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer
Swati Dhasmana, Anupam Dhasmana, Stella Rios, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5765-5775
Open Access | Times Cited: 2
Swati Dhasmana, Anupam Dhasmana, Stella Rios, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5765-5775
Open Access | Times Cited: 2
Post-translational modifications in drug resistance
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access
